Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Free Cash Flow (2022 - 2023)

Vycor Medical (VYCO) has disclosed Free Cash Flow for 6 consecutive years, with -$396.0 as the latest value for Q4 2023.

  • Quarterly Free Cash Flow rose 98.8% to -$396.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $23526.0 through Dec 2023, up 111.22% year-over-year, with the annual reading at -$18695.0 for FY2025, 134.15% down from the prior year.
  • Free Cash Flow for Q4 2023 was -$396.0 at Vycor Medical, up from -$14863.0 in the prior quarter.
  • The five-year high for Free Cash Flow was $24621.0 in Q1 2023, with the low at -$78780.0 in Q1 2022.